What chronic kidney disease stage corresponds to an estimated glomerular filtration rate of 50 mL/min/1.73 m²?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

An eGFR of 50 mL/min/1.73 m² corresponds to Stage 3a Chronic Kidney Disease

An estimated glomerular filtration rate (eGFR) of 50 mL/min/1.73 m² places a patient in Stage 3a CKD, defined as moderate decrease in kidney function with eGFR between 45-59 mL/min/1.73 m².

CKD Staging Framework

The KDIGO classification system, which is the internationally accepted standard, stages CKD based on eGFR ranges 1, 2:

  • Stage 1: eGFR ≥90 mL/min/1.73 m² with evidence of kidney damage
  • Stage 2: eGFR 60-89 mL/min/1.73 m² with evidence of kidney damage
  • Stage 3a: eGFR 45-59 mL/min/1.73 m² (moderate decrease)
  • Stage 3b: eGFR 30-44 mL/min/1.73 m² (moderate to severe decrease)
  • Stage 4: eGFR 15-29 mL/min/1.73 m² (severe decrease)
  • Stage 5: eGFR <15 mL/min/1.73 m² (kidney failure)

Why Stage 3a Specifically

With an eGFR of 50 mL/min/1.73 m², the patient falls into the 45-59 range, which defines Stage 3a 2. This represents approximately 40% of normal kidney function (normal being ~125 mL/min/1.73 m² in young adults) 1.

The subdivision of Stage 3 into 3a and 3b was implemented because research demonstrated substantially different prognosis between these groups 3. Patients with eGFR 30-44 (Stage 3b) have significantly higher risk of progression to end-stage renal disease compared to those with eGFR 45-59 (Stage 3a).

Clinical Significance at This Stage

At Stage 3a CKD, patients typically remain asymptomatic 4, but this level of kidney function carries important clinical implications:

  • Increased cardiovascular risk compared to normal kidney function 1, 5
  • Drug dosing adjustments become necessary for renally cleared medications 1
  • Risk stratification requires albuminuria assessment - the combination of eGFR and albumin-to-creatinine ratio (ACR) determines overall prognosis 1, 3, 6

Complete CKD Classification

The modern KDIGO framework emphasizes that CKD should be classified using the CGA system (Cause, GFR category, Albuminuria category) 1. An eGFR of 50 alone tells you the "G" category (G3a), but complete risk assessment requires:

  • Cause identification (diabetes, hypertension, glomerulonephritis, etc.)
  • Albuminuria category: A1 (ACR <30 mg/g), A2 (30-300 mg/g), or A3 (>300 mg/g)

A patient with Stage 3a CKD and heavy proteinuria (A3) has vastly different prognosis than one with Stage 3a and no proteinuria (A1) 3, 6.

Measurement Considerations

Recent evidence supports that eGFR calculated using both creatinine and cystatin C (eGFRcr-cys) most accurately reflects measured GFR and mortality risk 7. The 2021 CKD-EPI equations are now preferred over older formulas 6, 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.